| Board
of Directors Robert B. Cameron, M.D.
UCLA Medical School
Nicholas J. Vogelzang, M.D.
University of Chicago
M. Ann Abbe
Arlington, Texas
Michael Harbut, M.D., M.P.H.
Royal Oak, MI
Roger G. Worthington, Esq.
Dallas, Texas
Matthew Bergman, Esq.
Seattle, Washington
Susan Vento
St. Paul, Minnesota
Mouzetta Zumwalt-Weathers
Cary, North Carolina
Ulf Jungnelius M.D.
Pfizer, Inc.
In Memoriam
Congressman Bruce F. Vento
Science Advisory Board
Harvey Pass, M.D., Chairman
Karmanos Cancer Institute
Victor Roggli, M.D.
Duke University
Robert N. Taub, M.D.
Columbia University
Lary A. Robinson, M.D.
H. Lee Moffit Cancer Center
Steve Hahn, M.D.
University of Pennsylvania
Joseph R. Testa, Ph. D.
Fox Chase Cancer Center
Claire Verschraegen, M.D.
University of New Mexico
Eric Vallieres, M.D.
Swedish Cancer Institute
Dan Miller, M.D.
Emory University
Raphael Bueno, M.D.
Harvard/Brigham and Women's
Hedy Lee Kindler, M.D.
University of Chicago
W. Roy Smythe, M.D.
Texas A&M
Executive Director
Christopher E. Hahn
MARF, inc.
1609 Garden Street
Santa Barbara, CA 93101
tel (805) 560-8942
fax (805) 560-8962
c-hahn@marf.org
http://www.marf.org |

Our mission is to eradicate mesothelioma as a life-ending disease.
December 7, 2004
Mr.
Anthony Principi
Secretary of Veterans Affairs
810 Vermont Ave., NW
Washington, DC 20420
|
Re: |
|
CDMRP for Navy Veterans
Stricken with Service-Connected Malignant Mesothelioma
|
Dear Mr. Principi:
Mesothelioma is an asbestos-related cancer
that exacts a heavy toll on Navy veterans. Of the
4,000 Americans diagnosed with mesothelioma every year,
approximately 32% were exposed to asbestos while serving in the U.S.
Navy or while working in naval shipyards. Despite the heavy toll this
insidious cancer exacts on Navy servicemen, neither the Department of
Defense nor the Department of Veterans Affairs has a medical research
and treatment program for mesothelioma. Unfortunately, the National
Cancer Institute continues to grossly under fund mesothelioma research
when compared to other cancers.
We are asking for your cooperation in our
mission to persuade Congress to create a Congressionally Directed
Medical Research Program for Mesothelioma. Congress has created CDMRPs
for ovarian, prostate, breast and other cancers which are not
necessarily service-connected. From 1992 to 2005, Congress has
appropriated over $3.4 billion dollars to the DOD for specific research
priorities. The time is long overdue for Congress to recognize the
service and sacrifice of the thousands of veterans who either currently
suffer from an asbestos-related cancer or are at a substantial risk for
contracting same in the future.
The Mesothelioma Applied Research
Foundation (MARF) has united patients, doctors, lawyers and former
asbestos manufacturers in the mission to eradicate this terrible
disease. We have proposed
the creation of a $140 million
Mesothelioma Research and Treatment Program,
which would fund 10 centers of excellence, establish the Admiral Elmo
Zumwalt Registry and the Congressman Bruce Vento Tissue Bank. The
program MARF proposed was included in the Ban Asbestos Act (SB 1125), a
bill which is pending. There is widespread agreement that the merits of
a medical research program for asbestos cancer should be considered
separately from the rancorous debate over the need for asbestos civil
litigation tort reform.
We would like to discuss our proposal with
you. We envision a united front that includes the DVA and the DOD,
along with distinguished members of the scientific, medical, business
and legal communities. The creation of a federal program for
mesothelioma research should not be tied to the success or failure of
asbestos compensation reform legislation. With your support, we can
attract support from both sides of the aisle, as mesothelioma does not
respect party, rank, or title.
For your review, we are attaching a number
of memoranda, letters and articles which speak to MARF's history,
purpose and our impact within the medical and legal communities. The
attachments include a roadmap
for curing mesothelioma, a draft of the proposed $140 million
research and treatment program, a summary of the
grants
funded by MARF, an overview of MARF's
peer-review funding
mechanism, an article that discusses the
options for marshalling the resources
to fund medical research, and a
statement by a Navy veteran
afflicted with mesothelioma.
We will be calling you in the next few days
to discuss this letter and the next step. We look forward to
collaborating with you and your staff. We are also eager to follow up on our meeting last year, involving Chris
Hahn, Dr. Harvey Pass and Dr. Robert Cameron, over the
implementation of a database/registry for navy
veterans with asbestos disease.
Sincerely,
Roger G. Worthington
Founding Director
Enclosures
Cc: Jonathan B.
Perlin, M.D., Ph.D.
Department of Veterans Affairs
Acting Under Secretary for Health
810 Vermont Ave., NW
Washington, D.C. 20420
Mr. Rich Verma
Senior Counsel
Office of Senator
Harry Reid
528 Hart Senate
Office Building
Washington, D.C.
20510
Ms. Seema Singh
Legal Counsel
Office of Senator
Arlen Specter
711 Hart Building
Washington, D.C.
20510
|